Key result
TAVI procedures in Serbia show recent exponential growth, totaling 444 cases over a decade.
The TAVI program in Serbia has experienced exponential growth over its first decade, with 444 procedures performed since its inception in 2014.
Tracks exponential TAVI growth in Serbia; leaves open need for outcome registries and implementation studies.
Aortic stenosis (AS) is the most common valvular disease requiring surgical (SAVR) or transcatheter intervention (TAVI) in Europe and North America. The first TAVI was performed in 2002 in order to treat in-operable patients with AS, and the initial ESC guidelines recommended this procedure in patients with a high risk of SAVR. According to ESC guidelines for the treatment of valvular diseases from 2021, the decision on the treatment modality of AS is defined by the Heart team, and SAVR is recommended in younger patients with a low risk of surgery (<75 years STS-PROM/ EuroScore II<4%), and TAVI is recommended in elderly patients ≥75 years or in patients with high operative risk (STS-PROM/EuroScore II>8%) or in patients not suitable for surgery. In addition, large randomized clinical studies (PARTNER 3, Evolut Low Risk and NOTION studies) showed that TAVI is also safe in patients with a low operative risk (STS-PROM/EuroScore II<4%), and not inferior to SAVR (UK TAVI trial). The first TAVI procedure in Republic of Serbia was performed on April 22, 2014 during BASIC 8+ Congress. In the period of 2014-2023, 444 TAVI procedures were performed in Republic of Serbia, with exponential increase in in the last 2 years.
No takes yet. Share an insight, caveat, or question.
Nedeljković et al. (2023) studied this question. A total of 444 TAVI procedures were performed in Serbia between 2014 and 2023, showing an exponential increase in the last 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: